EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

68Ga/177Lu-Labeled Seribantumab as the Theranostic Drugs in Treating HER3-Positive Hepatocellular Carcinoma

Jiaojiao Li, Xiao Yang, Ao Li iD, Rou Li, Tao Wang, Xiaoxu Dong, Xiao Li, Qiang Xie, Changjing Zuo, Wei Zhang

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s646346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiaojiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lutetium, Antibodies, Monoclonal, Humanized. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLutetiumAntibodies, Monoclonal, HumanizedReceptor, ErbB-3Gallium RadioisotopesAntineoplastic AgentsTheranostic NanomedicineRadiopharmaceuticalsAntibodies, MonoclonalHumansAnimalsMiceRadioisotopesCell ProliferationTissue DistributionDrug Screening Assays, AntitumorHep G2 CellsStructure-Activity RelationshipDose-Response Relationship, DrugMice, Inbred BALB CMice, Nude

Stichwörter der Autor:innen

Seribantumabhepatocellular carcinomaradionuclide drug conjugates

Substanzen

LutetiumAntibodies, Monoclonal, HumanizedReceptor, ErbB-3seribantumabGallium RadioisotopesAntineoplastic AgentsERBB3 protein, humanLutetium-177Gallium-68Radioisotopes

Autor:innen und Institutionen

  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, People's Republic of China.
  • Department of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 200433, People's Republic of China.
  • Department of Nuclear Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Anhui, 230001, People's Republic of China.
  • Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.

ORCID-Profile: Ao Li

Zitieren

APA

Li, J., Yang, X., Li, A., Li, R., Wang, T., Dong, X., Li, X., Xie, Q., Zuo, C., & Zhang, W. (2026). 68Ga/177Lu-Labeled Seribantumab as the Theranostic Drugs in Treating HER3-Positive Hepatocellular Carcinoma. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s646346

Vancouver

Li J, Yang X, Li A, Li R, Wang T, Dong X, et al. 68Ga/177Lu-Labeled Seribantumab as the Theranostic Drugs in Treating HER3-Positive Hepatocellular Carcinoma. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s646346

BibTeX
@article{Li2026,
  author = {Li, Jiaojiao and Yang, Xiao and Li, Ao and Li, Rou and Wang, Tao and Dong, Xiaoxu and Li, Xiao and Xie, Qiang and Zuo, Changjing and Zhang, Wei},
  title = {68Ga/177Lu-Labeled Seribantumab as the Theranostic Drugs in Treating HER3-Positive Hepatocellular Carcinoma},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s646346}
}
Kostenlos starten →